Dr. Moorthy P. Ponnusamy's lab at the University of Nebraska Medical Center focuses on understanding how specific sugar molecules on proteins, called truncated O-glycans, affect the spread of pancreatic cancer. They investigate how these sugar alterations influence cancer behavior and contribute to the aggressive nature of the disease. Their work aims to develop potential new treatments by manipulating these sugar structures.

Dr. Rebecca E Oberley-Deegan's lab focuses on enhancing the safety and efficacy of radiation therapy for rectal cancer. The primary research investigates a novel antioxidant drug, BMX-001, which aims to protect normal tissues from damage while targeting cancer cells. The lab conducts preclinical studies and clinical trials to assess BMX-001's protective effects and identify biomarkers for radiation damage.